FDA Approved Products

Application #TypeSponsorNotesProduct #Drug NameFormStrengthActive IngredientApproval DateMarketing StatusReference Standard
202107NDACORCEPT THERAP001KORLYMTABLET;ORAL300MGMIFEPRISTONE2012-02-17PrescriptionYes